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            ABSTRACT 
This study is a retrospective, descriptive study that involved a review of 85 patient 
files from the Psychotherapy Unit (Ward 4&5) at Tara Hospital, admitted between 
01st January to 31st December 2012. The Psychotherapy Unit services patients with 
personality disorders, together with other comorbid disorders; and provides 
pharmacological and psychotherapeutic management to such individuals.  
The study described and analysed demographics, personality traits and disorders, 
details of substance misuse, taking into account gender and comorbid axis 1 
pathology. Options for referral to various substance use treatment facilities were 
considered, and presence of substance testing was also noted.  
The majority of patients included in the study were predominantly young, single, 
unemployed and female. The most common axis II diagnosis was borderline 
personality disorder. 81% of the individuals included in the study had a comorbid axis 
1 psychiatric pathology. Seventy-three percent of the study sample had a substance 
use disorder, with 33.9% meeting the criteria for substance dependence. There were 
significant differences observed between types of substances used and frequency, 
especially with regard to the different personality disorders. Also there was significant 
gender variability observed between the different personality disorder subtypes.  
This study highlights the high frequency of comorbidity between individuals with 
personality disorders and substance use disorders, and other axis 1 pathology in 
general. It necessitates the need to conduct further research in this group, and consider 
the possibility of opening a dual diagnosis unit on site, to provide adequate treatment 
to such a vulnerable subgroup. 
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INTRODUCTION 
Individuals with personality disorders and/or personality disorder traits commonly have 
substance abuse disorders. The two disorders may share common traits, such as feelings of 
inadequacy, marked impulsivity and a tendency towards self-damaging or risky behaviour, 
which may increase the likelihood of developing either disorder1. 
 
Individuals with more than one psychiatric disorder often do not receive adequate care, as 
appropriate services and facilities are often unavailable. Also, information is limited with 
regards to how to treat such individuals. It is well known that substance misuse negatively 
impacts the brain – leading to impaired judgement, cognition, memory and learning, and poor 
behaviour control; which worsens with ongoing use. Treatment is therefore vital.  
 
The hypothesis of this study was that there was a high incidence of alcohol and substance 
misuse disorders in patients with personality disorders. This study was a retrospective, 
descriptive study of patients admitted to the psychotherapy unit at Tara Hospital over a 
specific period of time. The number of individuals that were included (85) and met criteria 
for both/multiple disorders indicates that there is a growing need to screen and treat such 
individuals. The motivation for this study was to assess the need for a dual diagnosis unit on 
site. There is a need to treat such individuals in order to prevent a progression of further 
psychiatric symptoms and morbidity. 
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1) LITERATURE REVIEW 
“The co-occurrence of substance misuse with other psychiatric disorders is increasingly 
recognised as a major public health problem. The term ‘dual diagnosis’ has been introduced 
to describe this phenomenon, but ‘comorbidity’ is used as an alternative term”1. Psychiatric 
comorbidity is defined as the presence, either simultaneously or in succession, of two or more 
specific disorders in an individual within a specified period2. Comorbidity is substantial in the 
general population2.  
 
Tara Hospital is a specialised psychiatric facility located in Sandton, Johannesburg.  One of 
its highly specialised units is the Psychotherapy ward. Patients with personality disorders are 
admitted for a 6 - 8 week intensive psychotherapy program. Admission to the unit follows an 
outpatient assessment. Patients are screened for substance abuse disorders and are referred to 
drug treatment at centres elsewhere if the disorder is current. It is estimated that the Tara 
Psychotherapy Unit has a significant population of patients with personality disorders, with 
comorbid substance use disorders, that could benefit from the development of a dual 
diagnosis unit on site. Tara Hospital does not have a dual diagnosis unit nor are there any 
services available, in the surrounding catchment areas. The hospital is investigating 
introducing an outpatient dual diagnosis program. 
 
1.1) MOTIVATION FOR THE STUDY 
In South Africa, as in many other countries around the world, patients with comorbid mental 
illness and substance abuse disorders (“dually diagnosed” patients) have been a cause for 
concern, and often their needs are not met1,3,4. Mental disorders among South Africans often 
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go untreated, and efforts are clearly needed to improve access of those in need to existing 
mental health services. Eliminating deterrents to service utilisation, in particular stigma and 
inadequate referral systems between medical and mental health services, could help aid this 
problem4. Persons who have dual diagnosis use mental health and substance abuse treatment 
services more frequently, and their comorbidity has significant implications for service 
delivery5, 6. Low- and middle- income countries (including South Africa) spend less than 1% 
of their health budget on mental health4. Substance abuse and mental health treatment 
programmes are funded and managed separately, which may affect delivery of appropriate 
care. Rehabilitation centres and services generally fall under the domain of the department of 
Welfare and Social Services, and this contributes significantly to the fragmentation of 
services to mental health care users. The two treatment systems deal with individuals in 
different ways, and as resources in the public sector are scarce, each system tries to exclude 
individuals who are likely to require more resources, to fail in treatment, or cause disruption 
in programmes5,7. Studies have shown that South Africans seeking mental health care do not 
receive adequate care to meet treatment guideline standards, due to scarce resources4. Health 
service usage is disturbingly low among South Africans, with the vast majority of individuals 
with psychiatric disorders not receiving any form of treatment4. There is limited data on 
substance use in South Africa and other African countries3, 8.  Most of the available data are 
from secondary sources such as police records, where documentation is poor, particularly in 
rural areas, which makes the information unreliable.  
 
When dealing with comorbidity, it is frequently assumed that the substance use problems of 
psychiatric patients are less severe than those of patients in substance abuse treatment – in 
other words one illness takes priority over another9. Therefore, at some stage, certain aspects 
of both disorders are often overlooked. However it is important to keep in mind that patients 
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with comorbidity in the two types of treatment settings have overlapping symptoms. Neither 
illness can be ignored, and therefore some level of integrated treatment is necessary10.  
 
People with dual diagnosis often fall in-between the cracks of general psychiatry and 
specialist addiction services. Traditionally, addiction services are dedicated to ‘clients’ who 
want to be helped. Whereas general psychiatric services are obliged to treat all patients, even 
reluctant ones “detained” under the Mental Health Care Act. Furthermore, the limited 
availability of community care and rehabilitation facilities willing to admit mental health care 
users, adds to their troubles. Abou-Saleh described models with regards to the management 
of comorbidity: The serial treatment model involves management of the psychiatric disorder 
and substance misuse in separate settings and services1.  The parallel treatment model 
involves the concurrent treatment of substance misuse and psychiatric disorder using different 
staff and settings. Both the above models have serious limitations for optimal treatment, with 
high rates of patient withdrawal1. The preferred model is integrated treatment. Here the same 
staff treats both disorders in the same setting, which it is estimated improves overall health 
and functioning of patients, and appears to be effective1, 5, 11. Watkins and Burnam found that 
despite the recommendations that individuals who have co-occurring disorders receive 
treatment for their mental health and substance use problems, only 8% received either 
integrated or parallel treatment, which highlights the obvious problems encountered with 
service delivery5. 
 
The UK Department of Health launched the “Dual Diagnosis Good Practice Guide” in 2002, 
in which the key message stated was that substance misuse occurs often rather than rarely 
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among people with severe mental health problems; and that the relationship between the two 
disorders is complex17. It went on to say that individuals with dual diagnosis require high 
quality, comprehensive and integrated care that should be delivered within the mainstream 
mental health services; and that integrated care by a single team delivers better outcomes than 
serial care1. Based on the review by Abou-Saleh, integrated psycho education group therapy 
for in-patients is effective in improving comorbidity1. Multiple other studies have all 
demonstrated the effectiveness of a dual diagnosis approach1, 7. Thus the advantage of the 
integrated treatment was evident in terms of symptom improvement and reduction in 
substance use. “It seems fair to state then that a dual diagnosis programme that integrates 
elements of both psychiatric treatment and substance misuse treatment at its core, as well as 
offering other personalised treatment modalities would be of benefit to all patients concerned, 
as well as easing economic burden. With a dual diagnosis approach, treatment is guided by a 
comprehensive assessment, and integrated treatment that matches patient’s needs. It can be 
given in patient settings where the individual can be stabilised and assessed following 
detoxification, with staff holding a realistic and longitudinal view of treatment; taking into 
account different modalities of treatment such as motivational techniques to reduce substance 
use, multidisciplinary case management, medication supervision, urine drug screening, 
cognitive behavioural therapy and family interventions”1. This will all lead to improvement in 
substance misuse and quality of life1. 
 
Literature shows mental disorders to be significantly related to substance use disorders. These 
dual diagnoses are associated with severity and persistence of both mental and substance use 
disorders. Most people with dual diagnosis report their mental disorder occurred at an earlier 
age than their substance use disorder. “Some prospective studies confirm this temporal order, 
although significant predictive associations are reciprocal”12. Analyses suggest that some 
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primary mental disorders are markers and others are causal risk factors for secondary 
substance disorders12. Comorbid substance use is common amongst individuals with severe 
mental illness, and often these people suffer severe adverse consequences due to their 
substance use disorder. This is further confounded by the fact that traditional, separate 
services for individuals with dual diagnoses are ineffective. Dual diagnosis tends to be more 
common in those that are young, male, single, less educated, have a history of conduct 
disorder and family history of substance use disorder13. Research has shown that among 
people with serious mental illness, substance abuse is an underlying factor leading to violence 
and treatment non-compliance. Findings support the development of integrated treatment 
programmes that address both types of disorders14. Further research is needed on the 
organization and financing of dual diagnosis services, and on specific components of the 
integrated treatment model, such as family intervention. Newly emerging themes in the dual 
diagnoses literature includes concerns about the use of public funds for acquiring substances 
of abuse by persons receiving disability grants; and the vulnerability of psychiatric patients to 
HIV and other infectious diseases14. The introduction of the concept of the dual diagnosis in 
the late 1980’s was important in focussing attention on problems related to substance use 
among patients with severe mental illness in the community. Efforts now need to be geared 
towards preventing substance abuse, as well as helping dual diagnosis patients to recover. 
This can only be achieved through effective dual diagnosis programmes combining mental 
health and substance abuse interventions that are tailored for the complex needs of the 
clients’ comorbid disorders15. About 50% of individuals with severe mental disorders are 
affected by substance abuse, indicating that co-occurrence is common15. Comorbidity is so 
common according to Minkoff, that it should be expected rather than considered an 
exception16. 
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Often the individual is excluded from one service because of the comorbid disorder, and is 
told to return when the other problem is under control. The goal of dual diagnosis 
intervention is recovery from two serious illnesses – that is, the individual learns to manage 
both illnesses15. Effective programmes enable clients to gain access to service and maintain 
needed relationships with a consistent programme over time, thereby reducing non-
compliance rates15. Cumulative evidence from experimental research supports integrating 
outpatient mental health and substance abuse treatments into a single, cohesive package; and 
individualizes it to address personal factors and stage of motivation17, 18. 
 
1.2 RATES OF MENTAL ILLNESS COMORBID WITH VARIOUS SUBSTANCES 
The rate of substance misuse in subjects with severe mental illness is high7.  Substance 
misuse includes substance abuse and dependence.  Both involve a maladaptive pattern of 
substance use leading to clinically significant impairment or distress, occurring within a 
twelve month period19. However the disorders differ in their more infinite finer details, as 
described in the Diagnostic and Statistical Manual of Mental disorders, Fifth Edition19. 
Estimates of more recent or current abuse for those with mental illness in community samples 
in the United States of America (USA) range from 20% to 40%. These rates are higher than 
those for the general population7. Surveys in the USA, United Kingdom (UK) and Sub-
Saharan Africa have reported high rates of comorbidity, particularly substance misuse in 
people with serious mental illness. The overall prevalence of substance use in people affected 
with first episode psychosis is approximately double that in the general population of similar 
age22. Abou-Saleh documented prevalence rates of psychiatric disorders of 30% in alcohol 
dependence and 45% in drug dependence, compared with 12% prevalence in the non-
dependent population1. Several epidemiological studies completed in the past two decades 
have documented high prevalence rates of serious mental disorders co-occurring with 
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substance use disorders, and have indicated that at least one half of the patients in psychiatric 
and substance use treatment have been diagnosed with comorbid psychiatric and substance 
use disorders9. Most studies use samples taken exclusively from either mental health 
treatment or substance abuse treatment settings, but it is clear that patients with co-occurring 
disorders are found in both systems9. Ten Sub-Saharan African countries are among the 22 in 
the world with the highest increase in per capita alcohol consumption; with cannabis widely 
used and heroin use increasing3. Alcohol remains the substance most often used by South 
Africans (38.7%)8. Recent reports by the World Health Organization and the United Nations 
Office on Drugs and Crime show that per capita consumption of alcohol and the cultivation, 
trade, and consumption of cannabis are increasing in most African countries, with an 
inevitable increase in health and social problems3. Despite these increases, there is a lack of 
resources and programmes to deal with the problem.  
 
Comorbidity is greater in those meeting criteria for dependence of illicit drugs; and 
individuals with multiple dependencies experience the highest rates of psychiatric 
comorbidity20. Previous epidemiologic data suggests that of the individuals who have a 
current addictive disorder, almost half have a co-occurring mental disorder; and among 
individuals who have a current mental disorder – between 15% and 40% have a co-occurring 
addictive disorder. These studies further state that the temporal relationship between the 
disorders and the high proportion of primary lifetime conditions suggests that most are 
primary independent disorders – that is, one did not cause the other. Further implying that 
these people with co-occurring disorders will need treatment for both their mental illness and 
substance use problem5. Studies have shown that 45% of individuals with alcohol use 
disorders and 72% of individuals with drug use disorders had at least one co-occurring 
psychiatric disorder. The risk relationship appears to be reciprocal, with the presence of a 
psychiatric disorder predicting increasing risk of later substance use and vice versa20. It must 
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be kept in mind that the majority of patients may be unmotivated to change their substance 
use at the onset of treatment. Also, the patients symptoms might be a factor in the 
maintenance of substance use, and the drug and alcohol use might exacerbate the symptoms7. 
Addictive disorders are widespread in South Africa and other parts of Sub-Saharan Africa, 
and are on the increase. Alcohol remains the main psychoactive substance produced and 
consumed, and is associated with serious health and socioeconomic problems3. 
 
1.3)  BURDEN OF SUBSTANCE MISUSE AND MENTAL ILLNESS ON SOCIETY  
Comorbidity has major consequences. Individuals with co-occurring disorders have poorer 
treatment outcomes5. Subjects with comorbid disorders have higher service utilization rates 
than those with pure disorders2. Comorbidity has been linked to more severe symptoms, 
greater functional disability, longer illness course, more frequent hospital admissions, greater 
incidence of non compliance, delayed onset of symptom recovery, and higher rates of 
suicidality2, 10, 21, 22. This obviously has a negative impact on disease and economic burden, 
and healthcare overall. Thus, comorbidity represents an enormous public health problem. 
Comorbidity is also associated with increased risk of violence, and worse clinical and social 
outcome. The UK National Confidential Inquiry into Suicide and Homicide has reported 
substance misuse as a factor in over half of homicides and suicides by people with serious 
mental illness. Moreover, this group has been found to have high rates of criminality and 
blood-borne infections (including HIV, Hepatitis B and C)1.   
 
In South Africa, patterns of substance use have led to emerging problems such as HIV/AIDS, 
violence and marital disharmony within the home, poor family interaction, juvenile drinking 
in the home and delinquency, poor school attendance and performance, sexual problems, 
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underachievement, decreased work productivity, social dysfunction and homelessness, as 
well as financial and health problems. Often those most affected by alcohol head the 
household, resulting in social and economic problems in the family, poverty and child 
neglect8. It is also associated with poor treatment outcome and poor quality of life. Also, in a 
population where there is already a high prevalence of communicable diseases and increasing 
prevalence of noncommunicable diseases, such as diabetes and hypertension (and the 
complications thereof), life expectancy is lower, and access to health care is limited due to 
limited resources. National surveys and studies in the USA have mirrored the above 
findings23. This is significant as it renders a proportion of the population potentially 
unemployable and disabled; and continues to be a widespread and substantial public health 
concern. Treatment costs are also higher for those with a dual diagnosis, as compared to a 
person who has only one primary disorder5.  
 
In South Africa, a substantial proportion of the population are unemployed and homeless. 
Homeless people who have both mental illness and a diagnosis of substance abuse are an 
especially difficult population to treat, as their problems are numerous and severe. People 
with dual diagnosis spend more days homeless and report more involvement within the 
criminal justice system. They also have a lower subjective quality of life24. A study by Drake 
et al documented better treatment outcomes in this population with an integrated treatment 
approach25. It was also found that frequent contact with members of Alcoholics Anonymous 
(AA) or Narcotics Anonymous (NA) was associated with a reduction in alcohol use26. 
Substance misuse is a major risk factor for violence and disturbed behaviour in patients with 
a major mental disorder. Men with a major mental illness are 2.5 times more likely to commit 
a crime than men without mental illness and those people with alcohol dependency are at an 
even greater risk27.  
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1.4) ALCOHOL USE IN SUB-SAHARAN AFRICA  
All Sub-Saharan African states are classified as developing or low-income countries. They 
have many languages, cultures and heritages, and are at different stages of economic 
development and political stability. Limited information on alcohol and illicit substance 
misuse exists in these areas for many reasons – mainly due to limited resources for research 
and opportunities for publication. However since the 1960’s there has been rapid 
socioeconomic development and sociocultural changes across the African continent – 
resulting in rapid changes in the production, distribution and availability of alcohol, and the 
ways in which it is consumed. Also, European types of beverages and commercial production 
of new alcoholic drinks has been introduced, making it more widely and easily available. 
There has been a significant increase in alcohol consumption in Sub-Saharan Africa during 
the last 30 – 40 years. Uganda (one of the east african countries) has the highest per capita 
consumption of alcohol in the world3.  
 
The tendency to drink to intoxication on each drinking occasion has been noted in the World 
Health Organisation (WHO) global report under heavy episodic or binge drinking. It is stated 
in the report that several African countries have the highest rates of episodic heavy drinking, 
involving 52% of males and 40% of females in Nigeria3. In a community survey of adults in 
South Africa, it was found that alcohol abuse was the most prevalent lifetime health problem, 
affecting 11.4% of the population surveyed; of which 2.6% met the criteria for alcohol 
dependence3.  
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Prenatal use of alcohol exposes children to potentially devastating consequences of this 
teratogen – manifesting as growth retardation, microcephaly, mental retardation, 
characteristic dysmorphic facial appearance, as well as possible behavioural and learning 
problems. Collectively this phenomenon is known as Fetal Alcohol Syndrome (FAS)28. A 
South African study by Viljoen et al found that mothers with Fetal Alcohol Syndrome 
children had started drinking alcohol at an earlier age, had higher rates of heavy alcohol use 
in their families, were recurrent drinkers, and were drinking before and during pregnancy29. 
This further highlights the negative consequences and burdens placed on society due to 
ongoing alcohol usage; as well as point out possible areas for intervention.  
 
Where data is available, it shows that in all African communities, young males are more 
likely to drink alcohol than young females, alcohol use increases with age, and many believe 
the purpose of drinking is to get drunk. One study in Zimbabwe found that alcohol use was 
more prevalent among students with western cultural orientation than among those with 
traditional cultural orientation30. 
 
1.5) ILLICIT DRUG PROBLEMS IN AFRICA 
Cannabis remains the most widely available illicit drug in Africa3. Production, trafficking and 
consumption of illicit drugs is prevalent in Cameroon, Ethiopia, Kenya, Zimbabwe, Cote 
d’Ivoire, Ghana and Senegal – but is most acute in South Africa and Nigeria. In all the above 
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listed countries, the most prevalent use of cocaine and heroin is in South Africa, with the least 
amount used in Ethiopia. The most common method of drug usage is by smoking, and is 
mainly confined to cities and townships. Methaqualone and LSD (Lysergic Acid 
Diethylamide) is widely used in South Africa3. Since 2004, methamphetamine has become 
the primary drug of abuse in the Western Cape of South Africa. The use of heroin has 
steadily increased and so has the use of methcathinone (CAT)8. 
 
The WHO and United Nations Drug Control Programme performed a study involving South 
Africa, Tanzania and Zambia. They elicited that substance use was common in all three 
countries, and that the main substances used were alcohol, tobacco, painkillers and cannabis. 
They concluded that use and trade in illicit substances was common and often supplements 
families’ incomes31. A study carried out using university students as participants in Kenya 
found that lifetime use of alcohol was 84.2%, with cannabis use being 19.7%. 20% of 
students reported that they started using drugs in primary school3. Inhalant (volatile solvent) 
use is widespread among children and adolescents in Africa, especially those from the 
poorest economic backgrounds and broken families, those who have dropped out of school, 
are street children, or who are difficult to reach3.  
 
Cape Town, South Africa, continues to experience a dramatic increase in the use of crystal 
methamphetamine (known as Tik), which has become the primary substance of abuse there. 
Substance misuse is most prevalent among males in this area, with trends suggesting roughly 
a male female ratio of 8:28. Also, the use of all drug types has increased in younger 
populations, with younger cohorts starting to use ‘harder’ drugs (such as cocaine, heroin and 
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nyoape) at a younger age8. Results from The South African Stress and Health Study found 
that high rates of substance misuse were associated with living in an urban setting, high 
unemployment rates, and not completing high school. The study also found that alcohol was 
the most common substance used8. 
 
In South Africa, literature has documented a relationship between drug use and criminal 
behaviour. In a study carried out on people who had been arrested and detained in 8 police 
stations in South Africa, results revealed high levels of drug use among those detained; and 
45% of these individuals tested positive for either cannabis or mandrax3. Substance related 
problems in South Africa have increased dramatically over the past 10 years8. Such 
challenges faced include road traffic accidents, violence (including domestic violence) and 
severe crime committed under the influence of substances8. A Ugandan study found that 
women whose partners consumed alcohol before having sex faced a risk of domestic violence 
5 times higher than that of those whose partners did not drink before having sex3. 
 
Mentally ill patients may initiate drug use to self-medicate psychiatric symptoms, or some 
may develop mental disorders as a result of drug use. However, the comorbid occurrence of 
mental and substance use disorders in patients may also be a coincidental finding. As 
discussed above, patients with psychiatric disorders have an increased incidence of substance 
use disorders when compared to the general population. A study done by Weich et al at 
Stikland Hospital in the Western Cape, South Africa, documented that a comorbid substance 
use disorder (abuse or dependence) was diagnosed in 51% of patients; and that substance use 
disorders are prevalent among psychiatric inpatients and contribute to their morbidity. It is 
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also noted that few patients had ever received any interventions for their substance use 
disorder prior to admission – such as psycheducation, detoxification or rehabilitation32. 
Another Cape Town based study demonstrated that South Africa has a particularly high 
lifetime prevalence of substance use disorders; with early age at onset. Thus providing a 
possible important target for the planning of local mental health services33.  
 
1.6) SUBSTANCE MISUSE AND PERSONALITY DISORDERS 
Personality Disorders are highly prevalent co-morbid conditions among individuals addicted 
to substances34. Borderline personality disorder (BPD) and substance use disorders are two 
forms of psychological problems that are often diagnosed within the same person, and occur 
frequently. Borderline personality disorder diagnosis rarely occurs in isolation, and is often 
accompanied by a mood or substance use disorder diagnosis35. Substance use can contribute 
to problems of affective instability, impulsivity, and interpersonal problems (all features of 
borderline personality disorder). Also, individuals with borderline personality disorder might 
turn to substance use to ‘self-medicate’ the affective disturbance or to cope with feelings of 
emptiness or abandonement35.  
 
Substantial levels of impairment characterize borderline personality disorder. Individuals 
diagnosed are prone to attempt suicide, to seek out and utilize health care services, as well as 
to report significant levels of functional impairment. Rates of completed suicide for 
borderline personality disorder patients are estimated to be between 5 and 7%, and case-based 
studies indicate that borderline personality disorder is the most prevalent axis II diagnosis36. 
Also, borderline personality disorder appears to be an independent risk factor for suicidal 
behaviour over and above what can be accounted for by substance use disorders or other axis 
I psychopathology35. In a review of multiple studies that examined comorbid rates of 
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substance use disorders and borderline personality disorder diagnosed individuals, 57.4% of 
borderline personality disorder participants received a substance use disorder diagnosis; while 
48.8% met criteria for an alcohol use disorder35. Thus indicating that substance use disorders 
are prevalent in those with borderline personality disorder diagnosis. It can be hypothesized 
that the personality traits of affective instability and impulsivity are central to the 
development of both borderline personality disorder and substance use disorder, and, thus can 
account for much of the comorbidity between these disorders. It has been documented that 
borderline personality disorder is diagnosed at higher rates among women in general clinical 
samples and among women with substance use disorders35.  
 
With regard to antisocial personality disorder, prevalence rates have been shown to be high 
with regards to specific substance use37, 38. It is noted in multiple studies that drug abuse 
remains highly and significantly associated with other substance use disorders and antisocial 
personality disorder21. Recent data supports the relationship between antisocial personality 
and violence, especially when substance abuse is also present39, 40, 41. 
 
According to a recent study by Fenton et al, antisocial personality disorders were 
significantly associated with persistent alcohol and cannabis use disorders. Narcissistic, 
schizoid and obsessive-compulsive personality disorders were less consistently associated 
with substance use disorder persistance42. The association of antisocial personality disorder 
and its childhood antecedent, conduct disorder, with the risk for occurrence of substance use 
disorders is well known. In cross sectional general population research, all ten DSM-IV 
personality disorders were shown to have strong association with alcohol dependence and 
drug abuse and dependence. Further, personality disorders, by definition, characterized by 
extended duration, are associated with considerable impairment in functioning among those 
with alcohol dependence compared with those without personality disorders. However, the 
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relationship of personality disorders other than antisocial to the persistence of substance use 
disorders has been studied far less42.  
 
In the above study, antisocial, borderline, narcissistic and schizotypal personality disorders 
were found to be associated with persistent alcohol dependence42. Also important to note is 
that many treated substance abusers with antisocial personality disorder have other 
personality disorders, and aspects of substance outcomes may differ between antisocial 
substance abuse patients with and without other personality disorders. 
 
In an American study, the prevalence of narcissistic personality disorder among subjects with 
substance use disorders was 11.8%43. The prevalence of narcissistic personality disorder was 
significantly greater among men than women with alcohol use disorder and drug dependence. 
The prevalence of narcissistic personality disorder in the general population was 6.2%43. The 
rates of narcissistic personality disorder were generally greater among individuals who were 
separated, divorced or widowed43. Also significant was that they found that men with 
narcissistic personality disorder had higher rates of most substance use disorders and 
antisocial personality disorder, whereas women with narcissistic personality disorder 
generally had higher rates of major depressive disorder and anxiety disorders43. 
 
 
1.6.1) SUBSTANCE MISUSE WITH REGARD TO GENDER DIFFERENCES 
Compared with women with borderline personality disorder, men with borderline personality 
disorder appear to have more lifetime substance abuse disorders and antisocial personality 
traits44, 45. Gender appears likely to influence the degree of the substance use disorder and 
borderline personality disorder comorbidity, as well as prominent symptoms and associated 
clinical problems. Multiple findings have indicated that men with comorbid borderline 
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personality disorder and substance use disorders are more likely than women to present with 
multiple versus single substance use disorders35. Overall rates of substance use are 
significantly higher for males than females (for all substances except sedatives and 
tranquilizers). However, patterns of use, abuse, or dependence among users differ by age 
group and drug46.  
 
According to a London based study by Farrell, significant gender differences were found in 
the levels of alcohol consumption, with more men likely to report heavy drinking than 
women. Conversely women were more likely to be abstainers or to be occasional drinkers of 
alcohol compared to men. Heavy drinking was more prevalent among men aged 25 – 34 
years, where about 35 % were classed as heavy drinkers – compared with 15% of women. 
Also, 8% of men, and 2% of women were classified as alcohol dependent in this study. Men 
were also significantly more likely to have used an illegal or non-prescribed drug in the past6.  
 
Men who are younger, widowed/separated/divorced, of lower socioeconomic status, and 
living in urban areas are more likely to have antisocial syndromes and behaviour. In an 
American study virtually all associations between antisocial personality disorders and 
specific substance use disorders were positive and statistically significant37. Thus implying 
that comorbidity of specific substance disorders with antisocial personality disorders or 
syndromes is common, and more prevalent in the male gender. According to literature, not 
only are females much less likely to meet antisocial personality disorder diagnostic criteria, 
those that do are more likely to attribute their behaviour to substance use problems47. 
 
Recent literature shows that prevalence of narcissistic personality disorder is 6.2%, with rates 
greater for men (7.7%) than women (4.8%). An inverse relationship of narcissistic 
personality disorder with age is also observed43. Narcissistic personality disorder is associated 
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with considerable disability among men, whose rates exceed those of women. In a study by 
Stinson and Dawson, rates of alcohol abuse and dependence, and any other drug use disorder, 
was greater among men with narcissistic personality disorder than among women with 
narcissistic personality disorder; whereas women with narcissistic personality disorder had 
greater rates of mood and anxiety disorders (except panic disorder without agoraphobia and 
social phobia). In the total sample, prevalence of narcissistic personality disorder among 
subjects with substance use disorders was 8.8%43.  
 
With regard to other personality disorders, men with narcissistic personality disorder were 
significantly more likely than women with narcissistic personality disorder to have antisocial 
personality disorder, whereas women with narcissistic personality disorder were significantly 
more likely than men with narcissistic personality disorder to have borderline personality 
disorder43.  
 
Substance abuse and dependence may reflect attempts on the part of men with narcissistic 
personality disorder not only to re-establish or maintain grandiosity, but also to defend 
against the negative affect accompanying dysthymia that often accompanies aging and life’s 
inevitable limitations. Together, this suggests a propensity of men with narcissistic 
personality disorder of self-medicating to maintain a sense of omnipotence and grandiosity, 
to protect a fragile self-esteem, and to ameliorate feelings of depression, guilt, and 
worthlessness associated with dysthymia48. Also noted in literature has been a strong 
association between dependent personality disorder and drug dependence among men49. 
 
 
1.6.2) ALCOHOL MISUSE AND PERSONALITY DISORDERS 
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It remains difficult to accurately define the relationship between personality disorders and 
alcohol dependence. The reported prevalence of personality disorders in alcoholics ranges 
from as low as 22 – 40% 50. In a study by Escheburua et al, of the alcohol dependent sample, 
44.3% showed at least one personality disorder. Obsessive-compulsive personality disorder 
was most prevalent (12%), followed by antisocial, paranoid and dependent personality 
disorders (7% each), narcissistic (6.3%) and finally borderline and histrionic personality 
disorders (5.1% each). The most frequently diagnosed personality disorders among the non-
addicted patients were obsessive-compulsive personality disorder (9.2%), dependent 
personality disorder (6.1%), followed by paranoid personality disorder (4.2%). With respect 
to the three clusters of personality disorders, the presence of cluster B and C was higher 
among the alcoholic group24. Also, the high rate of comorbidity with personality disorders is 
different from and much higher in alcohol dependence than in any other Axis I mental 
disorder50. The above study also noted some preliminary conclusions, namely that obsessive-
compulsive, histrionic, schizoid and antisocial personality disorders are more frequently 
found in alcoholic women; whereas dependence is more frequently found in alcohol-
dependent men50. Results from the National Epidemiologic Survey on Alcohol and Related 
Conditions (NESARC) has found that twelve month alcohol dependence was significantly 
associated with only two axis II disorders, namely histrionic and antisocial personality 
disorders51. Findings from this study are consistent with previous studies which have 
documented that men are at greater risk of alcohol use disorders than women51. Dependence 
is clearly associated with increased rates of psychiatric disorders. It is mandatory that all 
clinicians assessing individuals with alcohol dependence screen for other psychiatric 
disorders too6. 
 
 
1.6.3) ALCOHOL ABUSE AND DEPENDENCE 
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Alcohol abuse and dependence is highly prevalent and disabling. Disability increases steadily 
and significantly with alcohol dependence severity. Alcohol dependence shows strong, 
significant associations with all other substance and psychiatric disorders; indicating that 
alcohol dependence remains highly comorbid with other disorders51. In a group of 900 HIV 
positive individuals studied in South Africa, depression was the most common psychiatric 
disorder, followed closely by alcohol abuse disorder. Thus highlighting its prevalence as a 
challenge in the general population, and in smaller subgroups52.  
 
A study by Hasin et al highlights that borderline personality disorder is a robust predictor of 
the persistence of alcohol use disorders42. Persistent alcohol dependence can also be predicted 
by narcissistic personality disorder42. A prospective study performed suggested that 
narcissistic personality traits predicted problem drinking during medical training53.  
 
An American study showed that among individuals with a current alcohol use disorder, 
28.6% had at least one personality disorder, whereas 47.7% of these with a current drug use 
disorder had at least one personality disorder. Further, 16.4% of individuals with at least one 
personality disorder had a current alcohol use disorder49. Associations between personality 
disorders and alcohol use disorders were overwhelmingly positive and significant49. Overall, 
alcohol use disorders were most strongly related to antisocial, histrionic and dependent 
personality disorders.  
 
 
1.6.4)    CANNABIS USE 
Cannabis is the most widely used illicit drug globally. Its use appears to be increasing in 
developed and developing countries. One in six adolescents who use cannabis in developed 
countries will develop dependence. Dependence carries an underappreciated risk; and is 
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associated with the use of other illicit drugs, which may lead to mood and psychotic 
disorders54. Three personality disorders have been found to predict persistent cannabis use 
disorders, namely antisocial, borderline and schizotypal personality disorder42. 
 
 
In conclusion, most of the South African and African literature focuses on prevalence of 
substance use disorders, but not much attention is paid to the impact of personality disorders 
or other axis 1 pathology on the above, and the interaction thereof. It would appear that 
research is lacking with regards to substance misuse and personality disorders in the South 
African context.  
 
HYPOTHESIS 
The hypothesis of the current study is that there is a high incidence of alcohol and substance 
use disorders in patients with personality disorders. This high prevalence necessitates a 
growing need to provide adequate psychiatric services for these comorbid patients, in the 
form of a dual diagnosis unit.  
 
 
The objectives of the study were as follows:  
1 To establish the rates of alcohol abuse and dependence in people with personality 
disorders admitted to the Tara Hospital Psychotherapy Unit.  
2 To determine the rate of comorbid substance abuse and personality disorders in 
patients admitted to the Psychotherapy Unit at Tara Hospital. 
3 To research if there are differences in the rates of abuse and dependence for the 
various substance use disorders. 
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4 To research gender differences in the rate of comorbid substance use disorders in 
patients admitted to the unit. 
5 To research if there are gender differences in the choice of substances of abuse.  
 
 
2) METHODS 
This study is a retrospective, descriptive study that involved a review of patient files from the 
Psychotherapy Unit (Ward 4&5) at Tara Hospital, over a 12 month period. Tara Hospital is 
located in Sandton, Johannesburg, and caters for the population in Northern Johannesburg 
and surrounding areas. The facility is a tertiary hospital, and is a specialised psychiatric 
institution. Ward 4&5 has a psychiatric registrar that rotates every 6 months as part of their 
required training; as well as a full multidisciplinary team, psychologists, occupational 
therapists, psychiatric nurses and a consultant psychiatrist. 
 
To accomplish the detailed literature review, resources were obtained by performing 
extensive searches in the Google scholar, PubMed, Cochrane library and Up To Date 
databases. 
 
The study population comprised all files of patients who were admitted to the Psychotherapy 
Unit at Tara Hospital from 01st January to 31st December 2012. This sample included people 
who have an Axis II personality disorder diagnosis. The Diagnostic and Statistical Manual of 
Mental Disorders, Fifth Edition describes a personality disorder as an enduring pattern of 
inner experience and behaviour that deviates markedly from the expectations of the 
individuals’ culture, is pervasive and inflexible, has an onset in adolescence or early 
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adulthood, and leads to stress or impairment19. The different personality disorders are: 
Paranoid, Schizoid, Schizotypal, Antisocial, Borderline, Histrionic, Narcissistic, Avoidant, 
Dependent, and Obsessive-Compulsive. The discharge summary book from the 
Psychotherapy Unit was used to ensure that all patients that entered the unit during the study 
period were included. Information was predominantly drawn from discharge summaries 
available in the patient’s files, as well as additional clinical notes available in patient files if 
necessary. There were 85 patients included in the study sample. Information for 1 patient was 
unavailable, as the file was missing.  
 
2.1) INCLUSION CRITERIA: 
 The study sample included all individuals over the age of 18, with an Axis II 
personality disorder, that were admitted to the unit between 01st January 2012 and 
31st December 2012. The sample could include patients with illicit, legal and/or over-
the-counter substance abuse/dependence.  
 
2.2) EXCLUSION CRITERIA: 
 There were no exclusion criteria. 
 
 
2.3) DATA COLLECTION 
The investigator identified and accessed the clinical files from the Tara Psychotherapy Unit 
and records department manually. Relevant data was extracted from these files. All data 
collection took place on the premises of Tara Hospital and no records were taken off the 
premises. Each file was allocated a number so that it remained confidential. Each participants 
file had a detailed discharge summary in it that was completed upon leaving the ward or 
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completing the programme, with all relevant information available. All assessments of files 
by the researcher were done at the unit, and all diagnosis were made according to DSM-IV-
TR criteria. Data collection sheets were used to aid the collection process (see Appendix: 
Data collection sheet). From the clinical files, the following information was obtained:  
 Demographic details (including exact age, gender, relationship/marital status, highest 
level of education, employment status and socioeconomic level). 
 Presence or absence of Axis I diagnosis, including details if present.  
 Presence of Axis II diagnosis, and specific personality disorder or traits present. 
 Substance use disorder, if present (including whether abuse or dependence or both 
was present). 
 Specific substance/s used. 
 Whether any referral to a substance use agency or equivalent was made in the past 
(e.g. SANCA, AA, NA). 
 Any record of confirmation of substance testing. 
 Noted if done in blood or urine. 
 Recorded as ‘positive’, ‘negative’ or ‘not done’. 
 
 
 
2.4) ETHICAL CONSIDERATIONS 
Consent from Tara Hospital CEO, Clinical Head and Research Committee were obtained for 
data collection from the file records. The Human Research and Ethics Committee of the 
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Witwatersrand University approved the study on the 24/01/2014, certificate clearance number 
M130917. In addition, informed consent from the patients and their families was not required 
as the names of the patients in the study remained anonymous. 
 
2.5) DATA ANALYSIS 
Data was captured on a Microsoft Excel spread sheet. Data analysis was carried out using 
SAS.  (SAS Institute Inc., SAS Software, version 9.3 for Windows, Cary, NC, USA: SAS 
Institute Inc. (2002-2010)). Between-group tests were conducted as follows:   
The Χ2 test was used to assess the relationships between categorical variables.  Fisher’s exact 
test was used for 2 x 2 tables or where the requirements for the Χ2 test could not be met.  The 
strength of the associations was measured by Cramer’s V and the phi coefficient respectively.  
The following scale of interpretation was used: 
0.50 and above   =    high/strong association 
0.30 to 0.49       = moderate association 
0.10 to 0.29       = weak association 
Below 0.10      = little if any association 
The 5% significance level was used throughout, unless specified otherwise.   
In other words, p-values <0.05 indicate significant results. 
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3) RESULTS 
 
3.1) DEMOGRAPHIC FACTORS 
 
A total of 87 patients were admitted to the unit during the study period. 85 patients were 
included in the study – as 2 patient files were missing. The mean age of the patients was 33.6 
years (standard deviation 8.4 years). The ages of patients ranged from 21 – 54 years old, with 
a median age of 33 years. The patients were predominantly young, with 75% of participants 
being below the age of 40 years. There were no patients in the 18 – 19 year old age group. 
The biggest grouping of participants (40%) was found in the 20 – 29 year old age group. 
Only 3.5 % of participants were found in the 50 – 59 year age group. This is represented 
below in figure 3.1.1. 
 
 
 
 
Twenty two percent of the patients were male. Patients were predominantly single (55.3%), 
with 16.5% currently divorced at time of admission. Fifteen percent were married, and 12.9% 
Figure 3.1.1: Distribution of age % 
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were attached or in a relationship at the time of admission to the unit, as represented in figure 
3.1.2.  
 
  
 
 
In terms of highest level of education attained, 65.9% of the patients had some form of 
secondary education (see figure 3.1.3). Only 5.9% of patients had a primary school education, 
with 28% of patients having obtained a tertiary level education in the past. Only 19% of 
patients were employed at the time of admission.  
 
Figure 3.1.2: Relationship status % 
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With regards to socioeconomic status, patients were classified into the following groups 
based on their income per annum. The H0 category is reserved for those who are on pensions 
or grants, and who receive all services free of charge. Individuals in the H1 category earn an 
income of less than R36000 per annum, with individuals in H3 category earning an income of 
greater or equal to R72000 per annum. The majority of patients were classified within the H1 
group (68.2%). Ten percent were classified in the H2 category, with 11.8% classified in the 
H3 group. Refer to figure 3.1.4. The H3 group is generally reserved for those who are on 
private medical aid schemes; with the H1 category commonly covering those who are 
destitute and unable to pay for admission themselves.   
Figure 3.1.3: Highest level of education % 
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3.2) AXIS II DIAGNOSIS 
All patients included in the study had an axis II personality disorder/ traits diagnosis. Sixty-
seven percent of the patients were found to have an axis II disorder, while 16.5% were found 
to have two axis II personality disorders. Figure 3.2.1. represents this information 
diagrammatically. Note that 16.5% of patients were found not to have an axis II personality 
disorder, however these individuals were found to have personality disorder traits (see figure 
3.2.2.). Thirty-four percent of patients were found to have only one personality trait on axis 
II. Two percent of individuals were found to have three axis II personality traits. As 
discussed, some patients were found to have more than one axis II diagnosis (see figure 
3.2.3.). The most common axis II diagnosis was borderline personality disorder (61%). The 
diagnosis of the various personality disorders was based on clinical interviews, mental state 
examinations, interactions observed and noted in the ward files; and a variety of group, 
Figure 3.1.4: Socio-economic level % 
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individual and specialized psychotherapy tests and techniques. Diagnostic criteria using 
DSM-IV TR was adhered to. The distinction between personality traits and disorders has 
been emphasized in order to draw parallels (and differences) between those individuals that 
may share traits within a cluster (for example: some clusters may be impulsive and reward 
seeking, and may therefore influence their substance intake). 
 
 
 
 
 
 
 
 
Figure 3.2.1: Axis II Personality Disorders % 
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Figure 3.2.2: Axis II Personality Traits % 
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Figure 3.2.3: Axis II diagnosis % 
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3.3) AXIS I DISORDERS 
 
Sixty-nine of the 85 patients included in the study (81%) had an axis I psychiatric diagnosis 
according to DSM-IV. Of those 69 patients with an axis I diagnosis, 62% had one disorder, 
while 32% had two disorders. Less than 10% of patients had three or four diagnosis 
respectively. See figure 3.3.1. below.  
 
 
 
 
 
 
 
 
The proportion of patients with each specific disorder is depicted below (figure 3.3.2). Note 
that the percentages do not sum up to 100%, since some patients had more than one disorder. 
Figure 3.3.1: Axis I diagnosis % 
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The most common axis I disorder encountered was major depressive disorder (24.6%). 
Dysthymia and generalised anxiety disorder was found to be 17.4% respectively. Ten percent 
of patients had a substance induced mood disorder, 13% had a diagnosis of bipolar disorder I; 
with 4.3% of patients having a diagnosis of adjustment disorder, bipolar disorder II or post-
traumatic stress disorder. Three percent of individuals in the study had conversion disorder, 
as well as somatoform disorder, and exhibited malingering behaviour respectively. The subset 
of patients admitted did not include any individuals with sleep or cognitive disorders.  
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Figure 3.3.2: Specific axis I diagnosis % 
Key: 
 NOS = not otherwise 
specified 
 GMC = general medical 
condition 
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3.4 SUBSTANCE USE DISORDERS 
 
62 of the 85 patients (72.9%) were found to have a substance use disorder (95% confidence 
interval: 63.5%-82.4%). This information was unavailable for 1 patient. Of the 62 patients 
who had a substance use disorder, 47 of these patients (75.8%) met the criteria for substance 
abuse (95% confidence interval: 65.2-86.5%). Alternatively, of the full study group of 84 
patients (information for 1 patient is missing), 56.0% (47 of the 84 patients) had substance 
abuse (95% confidence interval: 45.3-66.6%). Of the 62 patients who had a substance use 
disorder, 33.9% met the criteria for substance dependence (95% confidence interval: 22.1-
45.7%). Alternatively, of the full study group of 84 patients, 21 of these individuals (25%) 
had substance dependence (95% confidence interval: 15.7-24.3%). Diagnosis was based on 
clinical interviews, mental state examinations, and was based on DSM-IV criteria. According 
to patient files, a substance screening test was not done on all patients on admission – this 
may have been due to patients admitting to substance use, poor note taking or poor ward 
management. 
Of the 62 patients who had a substance use disorder, 9.7% (6 of the 62 patients) had both 
substance abuse and dependence (95% confidence interval: 2.3-17.0%), while 66.1% (41 of 
the 62 patients) had substance abuse only (95% confidence interval: 54.4-77.9%), and 24.2% 
(15 of the 62 patients) had substance dependence only (95% confidence interval: 13.5-
34.9%). 
Alternatively, of the study group of 84 patients, 7.1% (6 of the 84 patients) had both 
substance abuse and dependence (95% confidence interval: 1.6-12.7%), while 48.8% (41 of 
the 84 patients) had substance abuse only (95% confidence interval: 38.1-59.5%). Eighteen 
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percent (15 of the 84 patients) had substance dependence only (95% confidence interval: 9.7-
26.1%). 
In terms of the number of substances used, of the 62 patients with a substance use disorder, 
42% used one substance, while in other cases up to 6 substances were used (refer to figure 
3.4.1.). Twenty-four percent of patients used two substances, while 5% of patients used 6 
substances. Fifteen percent of patients used four substances. Of the 62 patients with a 
substance use disorder, 11% had polysubstance abuse.  
 
 
 
 
The proportion of patients using each substance is shown below in figure 3.4.2. Note that the 
percentages do not sum to 100%, since some patients used more than one substance. The 
Figure 3.4.1: Number of substances used % 
 40 
 
most common substances used were alcohol, at 58%; and cannabis, at 45%. Cocaine use was 
found to be 26% in the patient group, with nyoape use accounting for 2%. Benzodiazepine 
use accounted for 24%, and methamphetamine made up 23% in the patient group.  
In terms of alcohol use, of the 62 patients who had a substance use disorder, 36 of the 62 
patients (58.1%) used alcohol (95% confidence interval: 45.8- 70.4%). Alternatively, of the 
full study group of 84 patients, 42.9% (36 of the 84 patients) had an alcohol use disorder 
(95% confidence interval: 32.3-53.4%). 
 
 
 
Figure 3.4.2: Specific substances used % 
Key: CNSD = central nervous system depressant 
 CNSS = central nervous system stimulant 
 OTC = over the counter (medication) 
 GHB = gamma-Hydroxybutyric acid 
 PCP = phencyclidine 
 LSD = lysergic acid diethylamide 
 CAT = methcathinone 
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3.5) SUBSTANCE TESTING 
Only two patients out of the study group (2.4%) underwent substance testing. Both of these 
patients underwent urine testing, and not blood testing. One result was positive, and one was 
negative. Both had substance abuse (not dependence) disorders. Further analysis is 
meaningless due to the small group size.  
 
 
3.6) SUBSTANCE USE REFERRAL 
Substance use referral information was not recorded in the files in 32% of cases, so this 
information is of very limited use and the results should be interpreted with caution.  
Eighteen percent of the study group were referred, all of whom had a substance use disorder.  
For the 15 patients who were referred, the referral institutions are shown below in figure 
3.6.1.  Note that the percentages do not sum to 100%, since some patients were referred to 
more than one institution. Forty-seven percent of those referred were sent to AA (Alcoholics 
Anonymous). It was not noted or recorded in the files anywhere that any of the patients were 
referred to NA (Narcotics Anonymous). Of the patients referred, 20% were done so to 
various rehabilitation facilities. Forty-seven were referred to other facilities.  
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3.7) SUBSTANCE USE DISORDERS WITH REGARDS TO AXIS I AND AXIS II   
DIAGNOSIS 
 
The following significant differences were found within the data set:  
With regards to axis II diagnosis, there was a lower proportion of patients with narcissistic 
traits amongst those with a substance use disorder (10%) than amongst those without a 
substance use disorder (32%) (p=0.034; phi coefficient=0.27; weak association).  
There was a lower proportion of patients with dependent traits amongst those with a 
substance use disorder (13%) than amongst those without a substance use disorder (36%) 
(p=0.026; phi coefficient=0.27; weak association). 
Figure 3.6.1: Referral institutions % 
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With regards to axis I diagnosis, within the 68 patients with an axis I diagnosis, there was a 
lower proportion of patients with an adjustment disorder amongst those with a substance use 
disorder (0%) than amongst those without a substance use disorder (15%) (p=0.023; phi 
coefficient=0.33; moderate association). 
 
The mean age of patients with substance dependence was 36.8 years. The mean age for 
patients with substance dependence was higher than that of patients without substance 
dependence (mean 31.7y; sd=7.0y).  The effect size was moderate (Cohen’s d=0.66). 
There was a significant, moderate, association between the number of axis II traits and 
substance dependence (p=0.018; Cramer’s V=0.38). There was a higher proportion of 
patients with one or more axis II traits amongst those with substance dependence, compared 
to those who did not have substance dependence (see figure 3.7.1). Fifty-seven percent of 
patients with substance dependence had one axis II trait, compared to 24.4% of patients 
without substance dependence that had one axis II trait. Similarly, 4.8% of patients with 
substance dependence had 3 axis II traits, compared with 2.4% of patients without substance 
dependence that had three axis II traits.  
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With regards to substances used, there was a higher proportion of patients using 
benzodiazepines amongst those with substance dependence (43%) than amongst those 
without substance dependence (15%) (p=0.026; phi coefficient=0.31; moderate association).  
 
3.8) GENDER DIFFERENCES 
With regards to axis II diagnosis, in the patient sample there was a lower proportion of 
females with antisocial traits (3%) than males (26%) (p=0.005; phi coefficient=0.35; 
moderate association). In terms of substances used, there was a higher proportion of males 
using alcohol (94%) than females (46%) (p<0.0001; phi coefficient=0.43; moderate 
association). Also, it was found that there was a higher proportion of females using cannabis 
(54%) than males (19%) (p=0.019; phi coefficient=0.31; moderate association). There was a 
Figure 3.7.1: Association between Axis II traits 
and substance dependence  
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higher proportion of females using benzodiazepines (28%) than males (13%). Also noted is a 
relative difference between cocaine use between males and females in the sample group, with 
females using cocaine (28%) at a higher proportion than males (19%). Thirteen percent of 
females used LSD, whereas no males in the sample were recorded as using LSD. There was 
no use of GHB, aspirin or PCP in the study population. Two percent of females used nyoape, 
whereas no males used in the study sample. The results were the same for heroin and opioids. 
A higher proportion of females were using methamphetamines (24%) than males (19%). 19% 
of males used CAT compared to 20% of females. Values were close with regards to codeine 
use, with female use at 7%, and male at 6%. Similarly, the proportion of males (6%) using 
mandrax/methaqualone was similar to females (4%). A slightly higher proportion of females 
(11%) used a wider variety of other substances, than males (6%).  
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4) DISCUSSION 
This study is a retrospective review of patients 18 years and older admitted to the 
psychotherapy unit at Tara Hospital, with comorbid personality disorders and substance use 
disorders. To our knowledge there is no such study documented that has focussed on this 
subgroup in South Africa and the continent of Africa. There are international longitudinal 
studies, but none that take into account the various challenges and demands encountered in a 
South African context by the unique profile of patients presenting at Tara Hospital; or address 
and study the relevant pertinent substances among this subgroup of individuals. 
 
The hypotheses of this study was that the incidence of alcohol and substance use disorders in 
patients with comorbid personality disorders would be high. If found to be true, this high 
prevalence would add further evidence to necessitate the need to provide adequate psychiatric 
services for comorbid patients, in the form of a dual diagnosis unit, which Tara Hospital 
currently does not have.  
 
DEMOGRAPHIC FACTORS 
Eighty-five patients met inclusion criteria for the study. However only 84 patients were 
included in the study, as 1 patient file could not be found. The mean age of the patients was 
33.6 years, but the biggest grouping of patients was found in the 20 – 29 year old age group. 
Ages of patients ranged from 21 – 54 years, with a median age of 33 years. In this current 
study the majority of patients were young, predominantly below the age of 40. An 
international study done in 2008 found that borderline personality disorder was inversely 
related to age, with the decline in rates occurring after the age of 44 years44. These findings 
were also consistent with a 10 year longitudinal follow up study of inpatients with borderline 
personality disorder55. Patients with borderline personality disorder and other personality 
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disorders are more likely to present for admission when in crisis – which is usually during 
periods of stress.  
 
Patients admitted to the unit were predominantly single, divorced, unemployed and of low 
income status. A high percentage (65.9%) of these individuals had obtained some form of 
secondary education. Rates of borderline personality disorder have been noted in research to 
be significantly greater in those that are separated, divorced, widowed, and among those with 
low income and education44, 56. The fact that a high percentage of our study population 
obtained a secondary level education and are now unemployed, displays the chronic, 
debilitating and cyclical nature of such personality disorders, and associated mental illness.  
 
These results have demonstrated that individuals with personality disorders have a high 
frequency of unemployment, unstable and poor relationships, and present with low income. 
These unstable relationships lead them to have multiple failed relationships. The results 
further depict that there is an adult population that requires psychiatric intervention, and thus 
emphasis should be placed on the need to expand services to cater to this specific group. The 
current study is consistent with such findings. 
 
AXIS II DIAGNOSIS 
Sixty-seven percent of the patients were found to have an axis II disorder, while 16.5% were 
found to have 2 axis II personality disorders. Individuals could have a combination of one or 
more personality disorders or traits. Some patients just had personality disorder traits – which 
means they had some symptoms of the personality disorder, but did not have enough criteria 
to reach a diagnosis of the personality disorder. Having more than 1 personality disorder 
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diagnosis is common. There were no patients in the sample with schizoid, schizotypal or 
obsessive-compulsive personality disorder; or paranoid and schizotypal traits. The most 
common axis II diagnosis found in our study was borderline personality disorder, which is in 
keeping with most literature44. In an American study by Grant et al, findings reported were 
that the most prevalent personality disorders in a general population sample was obsessive-
compulsive disorder, followed by paranoid, antisocial, schizoid, and then dependent 
personality disorder57. However it must be noted that this sample differed substantially in that 
it was not performed on an inpatient sample, and therefore the patient sample demographics 
may have differed socially and culturally. Also the patient’s presentation and symptoms may 
have differed between an inpatient and outpatient setting.  
 
AXIS I DISORDERS 
Eighty-one percent of all patients had an axis I diagnosis (other than a substance use 
disorder). Sixty-two percent had one axis 1 disorder. Literature supports the strong and 
significant association between having an axis II diagnosis (especially borderline personality 
disorder) and other axis I disorders44.  
 
The most common axis I disorder was major depressive disorder at 24.6%, followed by 
dysthymia and generalised anxiety disorder at 17.4% respectively. A high percentage (13%) 
of total study patients also met criteria for bipolar disorder I. This could be due to the overlap 
in symptoms between bipolar 1 disorder and borderline personality disorder (impulsivity, 
affective instability). This study findings that personality disorders are most associated with 
affective and anxiety disorders is mirrored by previous literature56. In a study by Hasin et al 
looking at major depressive disorder, over 40% of participants had an anxiety disorder and 
over 30% had a personality disorder – demonstrating the strong association between the 
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various disorders58. All personality disorders assessed in the above literature had strong 
associations with major depressive disorder58.  
 
SUBSTANCE USE DISORDERS 
One of the aims of the study was to determine the rate of comorbid substance abuse in those 
with personality disorders admitted to the psychotherapy unit at Tara Hospital. 72.9% of the 
study population were found to have a substance use disorder. Of those, a greater majority 
had substance abuse than substance dependence. A certain percentage presented with both 
substance abuse and dependence, which could have been for multiple substances.  
 
Previous studies note that the rate and prevalence of personality disorders were greater among 
individuals with any drug abuse or dependence; or dependence on alcohol49. All specific 
personality disorders have been found to be strongly and consistently related to any alcohol 
use disorder49. More specifically, borderline personality disorder has been found to be a 
predictor of the persistence of alcohol and cannabis use disorders42. It is well documented that 
comorbidity among those with personality disorders and chronic users of alcohol, cannabis 
and nicotine is common42. Of significance in literature is that substance or alcohol abuse and 
dependence is steadily and significantly associated with lower social and emotional 
functioning and quality of life, greater disability over time, as well as increase in stressful life 
conditions – which will subsequently increase the risk for other psychiatric disorder (such as 
major depressive disorder)12, 23, 51. There is an overlap in prevalence between alcohol and 
drug dependence and general psychiatric comorbidity in general6.  
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The majority of patients used only 1 substance (42%). However some had polysubstance 
abuse. Comorbid substance use disorders are common amongst psychiatric inpatients and 
contributes to their morbidity32. The most common substance used was alcohol (58%), 
followed by cannabis (45%). This is in keeping with national and international literature on 
substance use. A study performed in the United Kingdom found that 80% of all participants 
had reported heavy consumption of alcohol in the 12 months preceding the study. Cannabis 
was the most commonly used drug in that area (5%) indicating that although it still retains its 
addictive popular nature, perhaps the consumption was less due to the demographic subset of 
patients6. Stimulants and hallucinogens followed at 1% each6. This was a large outpatient 
national survey involving over 15000 private households in Great Britain that were 
interviewed individually.  
 
Studies done in South Africa demonstrate that alcohol remains the substance most often used 
by the general population (38.7%), followed by cannabis use at 8.3%, which is in keeping 
with prior annual data from the World Drug Report. According to the South African Stress 
and Health Study, use of other drugs, including methamphetamine use, followed – which 
possibly might reflect an underestimation of drug use trends8, 32. In this study population it is 
useful to note that alcohol and cannabis were widely available, easily accessible, and 
relatively affordable when compared with other substances of abuse. Data collected from 
psychiatric inpatients at Stikland Hospital in the Western Cape of South Africa showed that 
comorbidity and violence were often the norm, and that cannabis and methamphetamine was 
often their preferred drug of choice32. 
 
In this study benzodiazepine use accounted for 24% of substances consumed. This is quite a 
high percentage but is possibly expected in a subset of individuals with a high rate of anxiety 
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disorders, sleep disorders, other psychiatric manifestations and possible comorbid dependent 
personality traits/disorders, thereby increasing the potential and possible opportunity for 
abuse. Methamphetamine use accounted for 22.6% of users in the current study. The abuse of 
methamphetamine is highly prevalent in the Western Cape of South Africa, and is the 
preferred drug of choice for patients in substance treatment programmes there8, 32. Heroin and 
opioid use accounted for 1.6%. Injection drug use populations are known to engage in high 
risk sexual behaviours, and have the potential to provide a significant contribution to the 
spread of HIV/Aids59. Twenty-six percent of individuals in the current study had a cocaine 
use disorder. In general, treatment admissions related to cocaine use in the general population 
have increased over time, but the current rate of increase appears to be much higher in the 
Eastern Cape region of South Africa than in Gauteng and Cape Town60. The category “OTC 
Other” included various analgesics which were readily available to patients without a 
doctor’s prescription.  
 
South Africas largest population, Black Africans, appear to have the lowest prevalence rates 
of illegal drugs usage other than cannabis. Even for cannabis, however, prevalence rates of 
cannabis use among black Africans is lower than in whites and coloureds61. Of increasing 
concern is that the age for initiation of drug use appears to be decreasing61. Cannabis users are 
often considered significantly less dangerous than someone who uses alcohol. Studies in 
South Africa have demonstrated that alcohol and cannabis are often considered ‘softer’ drugs 
(as compared to methamphetamine or heroin), which may further negatively impact the 
vicious cycle of alcohol-related injuries and crimes62.  
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SUBSTANCE TESTING 
Only 2.4% of the population sample underwent substance testing. This could possibly be due 
to the fact that the patients themselves admitted to using the various substances at the time of 
admission, and therefore testing was deemed unnecessary. The psychotherapy unit at Tara is 
a voluntary unit, and therefore no admission is forced. However, confirmation to ascertain the 
exact number of substances used by each individual and therefore correctly determine the 
presence/absence of polysubstance abuse would require testing to confirm such a diagnosis. It 
is improbable to assume that the individuals that were not tested were completely honest and 
reliable with regards to their substance use. This could be a possible limitation of the study. 
Also, in rare cases, urine and blood testing may produce unreliable results. For example: 
certain antibiotics can produce false-positive results for heroin and/or cocaine; or patients 
may knowingly switch urine specimens63. Therefore it is best in certain situations to rely on 
clinical judgement and examination. It is not policy of the psychotherapy unit to not test for 
substances.  
 
SUBSTANCE USE REFERRAL 
In this instance poor record keeping in patient files meant that only 32% of cases had 
information recorded regarding substance use referral. Eighteen percent of individuals had 
been referred to various referral facilities, sometimes more than one. Of note is that no 
individual was referred to Narcotics Anonymous. This may be due to the fact that Narcotics 
Anonymous meetings are held at Tara on a regular basis (however no mention was made of 
this in the patients discharge summaries). Twenty percent of those referred, were done so to 
various rehabilitation facilities – such as the dual diagnosis unit at Sterkfontein Hospital in 
Krugersdorp, Zamani at Chris Hani Baragwaneth Hospital in Soweto, or various other drug 
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rehabilitation facilities. Forty-seven percent were referred to other facilities such as Gamblers 
Anonymous, Child Welfare Societies, and various individual and group support therapy.  
 
In a study done on known psychiatric patients with substance use disorders at a hospital in 
Western Cape, South Africa, it was discovered that few patients had documented evidence of 
any prior interventions for their substance use disorders. It was discovered that only 3% had 
received prior psycho-education, 0.7% had received detoxification in the past, 0.7% had been 
to outpatient rehabilitation, and 3% had attended inpatient rehabilitation32. This study, 
together with the current study, highlights that not enough attention is paid to the comorbid 
treatment and rehabilitation of such individuals; which goes on to contribute to the increasing 
health burden. Few patients are receiving adequate interventions for their comorbid problem. 
If not offered the opportunity of rehabilitation services, many are not aware of how to 
proceed to get help. Studies conducted among treatment centres in Gauteng province in South 
Africa between 2003 and 2004 found that they didn’t provide gender sensitive and focussed 
treatment programmes, which were accessible64. A Cape Town study performed in 2014 
showed that a large proportion of the study sample of substance users recognized that they 
needed treatment, and were willing to receive treatment, yet close to half the sample were 
unaware of where they could obtain treatment - indicating substantial unmet treatmet needs 
among young women from disadvantaged communities65. So it can be hypothesized that 
there are deficits in the system with regards to the referrals availability of treatment facilities, 
with barriers to access help. People are also more likely to seek treatment if it has been 
suggested to them66. This is particularly important with regards to personality disorder 
patients, where often part of the pathology may involve not accepting responsibility or taking 
actions to solve the problems. Individuals with borderline personality disorder are likely to 
seek out and utilize health care services, but it is unlikely that they will accept responsibility 
or their role in the problem18.  
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SUBSTANCE USE DISORDERS WITH REGARDS TO AXIS I AND II DIAGNOSIS 
In this study it was found that narcissistic personality disorder traits was more prevalent 
amongst those without a substance use disorder (32%). In other words, it was found there was 
a weak association between narcissistic traits and substance use disorders (10%).  
 
Literature has found that narcissistic personality disorder is significantly associated with drug 
dependence, except for alcohol abuse. Other studies have found the prevalence of substance 
use among respondents with narcissistic personality disorder to be around 60%43. It is noted 
that substance abuse and dependence may reflect attempts on part of men with narcissistic 
personality disorder to re-establish or maintain grandiosity, by behaviour, to defend oneself 
against negative affect, ageing and life’s inevitable limitations43. Perhaps, in our current 
study, the prevalence of narcissistic traits is so low due to the large percentage of the study 
sample being female. It has been documented that higher rates of narcissistic personality 
disorder are found among men than among women43. In contrast other studies have 
documented that narcissistic, schizoid and obsessive-compulsive personality disorders have 
been less consistently associated with substance use disorder persistence42. A study by Hasin 
et al found that antisocial, borderline and schizotypal personality disorders significantly and 
robustly predicted the persistence of substance use disorders42. These findings suggest merit 
in replication and further investigation of the above relationships. Evidence linking 
narcissistic personality disorders with substance use disorders remains mixed when more 
recent clinical studies are considered43. 
 
In the current study it was found that individuals with dependent personality disorder traits 
had a weaker association with a substance use disorder (13%), compared to those without 
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(36%). In other words, dependent personality disorder traits was found to be more prevalent 
in those without a substance use disorder. A study by Escheburua found that certain 
personality disorders were more frequent in alcoholic women; and that dependent traits were 
more frequent in alcohol-dependent men50. Once again this could account partly for the lower 
number of individuals presenting with dependent personality disorder traits in our study. 
Twenty-two percent of the current study population were male.  
As previously mentioned, of the 62 patients that had a substance use disorder, 58.1% used 
alcohol. Whereas 42.9% of the study population of 84 individuals had some kind of alcohol 
use. The most common axis II personality disorder was borderline personality disorder. 
Studies have documented that substance use disorders increase the chronicity of borderline 
personality disorder, and that borderline personality disorder increases the chronicity of 
substance use disorders. Research investigating the relationships between personality and 
alcohol sensitivity has documented that there is an association between the trait of 
impulsivity/disinhibition and the stress-reducing properties of alcohol 35,67. Also individual 
differences in reactions to alcohol have been shown to prospectively predict alcohol 
problems67. Impulsivity/disinhibition is a central feature of borderline personality disorder, 
and may influence an individual’s decision to use substances. Impulsivity serves as a risk 
factor for both borderline personality disorder and substance use disorders, especially alcohol 
use disorders35. Thus the pharmacological properties of alcohol may provide some temporary 
relief, and there seems to be a general tendency to attempt to deal with negative affective 
states with substances35. Certain personality disorders share common traits of engaging in 
behaviours that are potentially risky and self-damaging. Alcohol abuse in itself is a predictor 
of risky sexual behaviour68. The combination of such a personality disorder, and a substance 
use disorder is especially problematic and dangerous.  
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As with recent literature, the current study also documented that the prevalence of specific 
personality disorders was greater among respondents with dependence on alcohol and/or 
drugs49. Individuals with antisocial personality disorder tend to be impulsive, seductive, 
superficially seeking excitement, reckless and can be manipulative49. There is a strong 
relationship observed between antisocial personality disorder and traits, and substance use 
disorders; which was also demonstrated in this current study42, 49. Also, there is a strong 
association between most personality disorders and substance use disorders, and this is 
generally consistent49.  
 
In light of such extensive comorbidity between personality disorders and substance use 
disorders, it appears there is great value in further assessing personality disorder and 
substance use disorder patients, which could guide treatment planning. Such patients can be 
expected to require treatment that is more extensive, of longer duration and more 
individualized. With this in mind, the concept of a dual diagnosis unit might hold promise for 
future recovery of comorbid individuals.  
 
The current study also revealed evidence that there was a higher proportion of patients with 
one or more axis II traits amongst those with substance dependence, compared to those 
without. Comorbidity among personality disorders with regards to the number of traits or 
personality disorder diagnosis is common42.  
 
GENDER DIFFERENCES 
More males were found to have antisocial traits in our study. It is well known and understood 
that males are generally more antisocial than females, and exhibit more antisocial traits and 
 57 
 
behaviours37, 69. Females are less likely to meet criteria for antisocial personality diagnostic 
criteria, and those that do are more likely to attribute their behaviour to substance use 
problems47.  
 
Impulsive behaviours considered most relevant to borderline personality disorder (for 
example: suicidal gestures) and substance use disorders (for example: aggression, violence 
towards others), respectively, may reflect gender differences in prevalence rates for each 
disorder. Specifically, higher rates of substance use disorders are observed among men, and 
men are more likely to commit aggressive acts aimed at others. Most existing studies suggest 
that borderline personality disorder is more commonly diagnosed in women, who are more 
likely to make suicidal gestures35. These gender differences in the typology of impulsive acts 
may reflect the influence of culture or a biologically mediated mechanism.  
 
There was a higher proportion of females using cannabis and benzodiazepines, but more 
males using alcohol in the study population. Females were found to use cocaine at a higher 
proportion than males, as well as LSD and nyoape (but in small amounts). This was the same 
for heroin, opioids and methamphetamines – with a higher proportion of females using than 
males in the current study. Figures were similar with regards to use for both genders for 
codeine, CAT and mandrax. According to the South African Stress and Health Study, gender 
was found to be the most significant indicator of substance use, with males generally 8 – 9 
times more likely than females to become users of all drug types (except for extra-medical 
drugs and over the counter preparations). Thus indicating that males had a considerably 
higher prevalence of substance use compared with females3, 8. Gender thus appears likely to 
influence the degree of substance use disorder, as well as borderline personality disorder 
comorbidity; and prominent symptoms and associated clinical problems. Borderline 
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personality disorder has been documented to be diagnosed at higher rates among women in 
clinical samples with substance use disorders35.  
 
5) LIMITATIONS 
Although the sample size of individuals with personality disorders in the study was sizeable, 
a larger sample size would have been beneficial in making the results more generalizable to a 
larger general population. Basically no research could be sourced in South Africa on this 
specific topic, emphasizing the need for research in this comorbid population.  
 
This study was a retrospective review of file records, and information used was therefore 
highly reliant on entries and diagnosis made by other clinicians and mental health 
professionals. Due to human error, there was a file that was missing, and some information 
that was not recorded in files. Files that were missing made the sample size even smaller. The 
patients were also assessed by a number of different clinicians and mental health 
professionals, and there was no use of a uniform diagnostic tool documented in the file as part 
of the initial assessment. The diagnosis of each patient was clinically based and this may have 
resulted in diagnosis being missed or misinterpreted in some instances. As previously 
mentioned, very few patients in the study sample were tested for substances in the 
psychotherapy unit. This bases the assessment of patients solely on subjective reports. Also 
the small number of male patients may have made the gender specific questions problematic. 
It may be the reason that the percentage of men in the study using substances was lower than 
that of women. Another limitation may have been the selection criteria used to admit patients 
to the programme. Due to scarce resources, it may be that only patients with a good prognosis 
get selected to the unit.  
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As Tara Hospital is situated in the northern suburbs of Johannesburg, it is possible to assume 
that the study population was of a more affluent class, with possible over-representation of 
white and highly educated patients compared to the rest of South Africa’s population. It is 
difficult to generalise the results of this study to the rest of the population.  
 
6) CONCLUSION 
This study highlights the comorbidity between personality disorders and substance use 
disorders in the general population. It necessitates the need to conduct further research on this 
topic. The evidence suggests that individuals with various personality disorders present with 
a high prevalence of comorbid substance use disorders, and highlights the growing need to 
provide adequate psychiatric services to this vulnerable population – in the form of a dual 
diagnosis unit. The current study may be viewed as a pilot study for larger audits that cater to 
similar study populations. General practitioners, psychiatrists and all mental health 
professionals need to be aware of the high prevalence of substance use disorders among those 
with personality disorders; as well as how and when to refer, and ensuring management of 
both illnesses. Currently in most settings, there are no or minimal facilities available to 
adequately address both the comorbid personality disorder and substance use disorder of such 
individuals. The implementation of a dual diagnosis unit on site at Tara Hospital would 
adequately address both the above pathology, and may decrease morbidity. More research 
and intervention programs should ideally target this subgroup of individuals, as substance use 
is on the increase and is a major public health problem, with many individuals using multiple 
substances. Substance use disorders are prevalent among those with personality disorders, 
and impact negatively on the patients’ wellbeing, and add to the burden of service delivery. 
However, few patients receive interventions or are referred for their comorbid problems. This 
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retrospective review heightens the awareness of psychopathology in those with personality 
disorders, and as a result could emphasize the need for research, education and development 
of psychiatric services for such a population.  
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